Trouble for Darwin’s Frogs

Chytrid fungus has likely driven the decline of two South American frog species named for Charles Darwin.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

R. darwiniiCLAUDIO SOTO-AZAT, ZOOLOGICAL SOCIETY OF LONDONBatrachochytrium dendrobatidis (Bd)—is a skin infection that kills amphibians around the world. Two affected species, Rhinoderma rufum and R. darwinii, are found in Chile and Argentina and called Darwin’s frogs, based on Charles Darwin’s involvement in their discovery. Scientists from England, Germany, and Chile have now shown that Bd was likely involved in the extinction of R. rufum and the decline of R. darwinii. Their work was published in PLOS ONE this week (November 20).

The researchers sampled for Bd in multiple species of wild amphibians in Rhinoderma native habitats in Chile and Argentina and preserved specimens in museums in South America and Europe. They found that all the Bd-positive archived amphibians had been collected in the 1970s, around the time that numbers of Darwin’s frogs began to decrease and that 12.5 percent of living amphibians in the Rhinoderma home range were infected. The scientists found no living R. rufum animals, which confirmed their conclusion—published this summer (June 12) in PLOS ONE—that R. rufum had gone extinct. Infection percentage in R. darwinii was close to 2 percent, which was much lower than the general amphibian population and suggested to the team that R. darwinii frogs may be highly susceptible to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies